Presented by
Management Forum
The Financial Benefits of Quality Risk Management In-house Training
In this talk, explore how the Quality Risk Management (QRM) impacts the financials of an organisation and how it can enhance an organisation's financial strength.
- Format: Bespoke training
- CPD: 1.5 hours for your records (depending on your requirements)
- Certificate of completion
Part of Making Financial Sense of GMP series:
Are you aware of how the GxP requirements impact the financials of an organisation? This exciting series provides a concise overview of some key elements of GxP such as Pharmaceutical Quality System, Validation Master Plan, Risk Management and Change Management. Participants will learn about how these elements impact the gross profit, operational costs and net profit.
Course overview
Quality Risk Management (QRM) is outlined in ICH Q9 guideline. The importance of quality systems has been recognised in the pharmaceutical industry and it is evident that quality risk management is a valuable component of an effective quality system.
The QRM includes the following elements:
- Risk Assessment
- Risk Control
- Risk Review
- Risk Communication
Working with QRM has cost implications. When used effectively, QRM can be used for cost vs benefit analysis. What are the financial risks involved if an organisation does not implement an effective Vendor Approval System or a Validation Master Plan? Is QRM and expectation or a must for an organisation?
This course is part of our GxP training (Good x Practice) course collection, which features a variety of topic areas to ensure you comply with the most recent quality guidelines.
Benefits of attending
Attending this session will help deepen your knowledge and support your understanding on how the Quality Risk Management (QRM) benefits an organisation's financial performance.
The benefits of attending this session include:
- Learn about the impact of QRM on the gross profit, operational costs and net profit
- Explore how QRM can support efforts to reduce costs and improve profits
- Discuss QRM elements that contribute to cost reduction
- Understand how financial decisions don't have to compromise QRM
- Consider what would happen if QRM was not a regulatory expectation
Who should attend?
This session is designed for senior life science professionals involved with Quality Risk Management (QRM) either directly or indirectly.
The stakeholders are typically from executive and management roles responsible for and involved in decision making and striving to balance financial goals with compliance and quality requirements.
Other interested stakeholders not directly involved with compliance or quality include:
- Chief Operating Officers
- Chief Financial Officers
- Finance and costing analysts
United Kingdom
- University of Sheffield
